HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John K Erban Selected Research

Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)

1/2007Autoimmune hemolytic anemia in patients with liver transplants for primary biliary cirrhosis: Three case reports and a review of the literature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John K Erban Research Topics

Disease

12Breast Neoplasms (Breast Cancer)
01/2021 - 09/2002
3Neoplasms (Cancer)
08/2019 - 03/2011
2Amenorrhea
03/2011 - 06/2010
2Hemorrhage
02/2003 - 03/2002
1Chronic Pain
12/2020
1Mood Disorders (Mood Disorder)
12/2020
1Triple Negative Breast Neoplasms
08/2019
1Prediabetic State (Prediabetes)
01/2019
1Cardiotoxicity
01/2019
1Overweight
01/2019
1Type 2 Diabetes Mellitus (MODY)
01/2019
1Heart Failure
01/2019
1Eosinophilia
01/2017
1Embolic Stroke
01/2017
1Hypereosinophilic Syndrome (Loeffler Endocarditis)
01/2017
1Lung Diseases (Lung Disease)
12/2014
1Pulmonary Alveolar Proteinosis
12/2014
1Respiratory Insufficiency (Respiratory Failure)
12/2014
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2014
1Hematologic Neoplasms (Hematological Malignancy)
12/2014
1Febrile Neutropenia
04/2007
1Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
01/2007
1Hemolytic Anemia
01/2007
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2007
1Hemolysis
01/2007
1Anemia
01/2007
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2007
1Fever (Fevers)
02/2006
1Constipation
02/2006
1Neutropenia
02/2006
1Carcinoid Tumor (Carcinoid)
01/2004
1Liver Diseases (Liver Disease)
02/2003
1Endometrial Neoplasms (Endometrial Cancer)
09/2002
1Thrombophilia
03/2002
1Venous Thromboembolism
03/2002

Drug/Important Bio-Agent (IBA)

4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 02/2006
3TamoxifenFDA LinkGeneric
03/2011 - 09/2002
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2010 - 02/2006
3Docetaxel (Taxotere)FDA Link
06/2010 - 02/2006
2Hormones (Hormone)IBA
12/2020 - 03/2011
2ErbB Receptors (EGF Receptor)IBA
01/2019 - 04/2007
2AnthracyclinesIBA
01/2019 - 06/2010
2Rituximab (Mabthera)FDA Link
12/2014 - 01/2007
2QuinolonesIBA
04/2007 - 02/2006
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2007 - 02/2006
2Vinorelbine (Navelbine)FDA LinkGeneric
04/2007 - 02/2006
2factor V LeidenIBA
02/2003 - 03/2002
2AnticoagulantsIBA
02/2003 - 03/2002
1Poly Adenosine Diphosphate RiboseIBA
08/2019
1pembrolizumabIBA
08/2019
1niraparibIBA
08/2019
1antineoplaston A10 (A 10)IBA
01/2019
1taxaneIBA
01/2019
1Biological ProductsIBA
01/2019
1Dihydrotachysterol (AT 10)IBA
01/2019
1Vitamin DFDA LinkGeneric
01/2019
1apixabanIBA
01/2017
1TroponinIBA
01/2017
1Prednisone (Sone)FDA LinkGeneric
01/2017
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
12/2014
1Bendamustine HydrochlorideFDA Link
12/2014
1AntibodiesIBA
12/2014
1LipidsIBA
12/2014
1Proteins (Proteins, Gene)FDA Link
12/2014
1Pulmonary Surfactants (Pulmonary Surfactant)IBA
12/2014
1Surface-Active Agents (Surfactants)IBA
12/2014
1Taxoids (Taxanes)IBA
06/2010
1Estrogen ReceptorsIBA
06/2010
1Trastuzumab (Herceptin)FDA Link
04/2007
1human ERBB2 proteinIBA
04/2007
1SteroidsIBA
01/2007
1Letrozole (Femara)FDA LinkGeneric
04/2006
1LaxativesIBA
02/2006
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2006
1Interferon-gamma (Interferon, gamma)IBA
01/2004
1Prothrombin (Factor II)IBA
03/2002

Therapy/Procedure

6Therapeutics
12/2020 - 03/2002
4Drug Therapy (Chemotherapy)
01/2019 - 08/2006
3Neoadjuvant Therapy
02/2017 - 02/2006
2Adjuvant Chemotherapy
01/2021 - 03/2011
1Secondary Prevention
12/2020
1Treatment Delay
01/2020
1Liver Transplantation
01/2007
1Preoperative Care
02/2003
1Aftercare (After-Treatment)
09/2002